Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Healthcare Medical Devices
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Recent & Breaking News (NDAQ:AEMD)

The Hunt for Virus Treatments Continues Post Covid-19

Newsfile June 7, 2024

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Newsfile June 3, 2024

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

PR Newswire June 3, 2024

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

PR Newswire May 15, 2024

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

PR Newswire May 10, 2024

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

PR Newswire February 21, 2024

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

PR Newswire February 14, 2024

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

PR Newswire February 7, 2024

Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

PR Newswire November 14, 2023

Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer

PR Newswire November 13, 2023

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

PR Newswire November 6, 2023

Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology

PR Newswire October 10, 2023

Aethlon Announces Reverse Stock Split

PR Newswire October 4, 2023

Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference

PR Newswire August 30, 2023

Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update

PR Newswire August 10, 2023

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023

PR Newswire August 3, 2023

Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant

PR Newswire July 24, 2023

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors

PR Newswire July 6, 2023

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

PR Newswire June 28, 2023

Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023

PR Newswire June 22, 2023